This inventor holds 3 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Millennium Pharmaceuticals Limited, Wyeth. Active years: 2002-2006.
Company Filing History:
1 out of 1,264 
1 out of 854 
1 out of 1,309 
Years Active: 2002-2006
Title: Wengian An: Innovator in Potassium Channel Research
Introduction
Wengian An is a notable inventor based in Framingham, MA (US). He has made significant contributions to the field of biochemistry, particularly in the study of potassium channels. With a total of 3 patents to his name, An's work has implications for various medical and therapeutic applications.
Latest Patents
One of Wengian An's latest patents is titled "Potassium channel interacting polypeptides and uses thereof." This invention provides isolated nucleic acid molecules, designated PCIP nucleic acid molecules, which encode proteins that bind potassium channels and modulate potassium channel-mediated activities. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing PCIP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PCIP gene has been introduced or disrupted. Additionally, the invention provides isolated PCIP proteins, fusion proteins, antigenic peptides, and anti-PCIP antibodies. Diagnostic methods utilizing compositions of this invention are also included.
Another significant patent by An is focused on the "Cloning and characterization of a cdc15-like adaptor protein (CD2BP1)." This patent describes a human CD2 cytoplasmic tail binding protein, CD2BP1, along with the nucleic acids encoding the protein. It also details expression vectors and recombinant host cells comprising nucleic acids encoding the CD2BP1 protein, as well as methods of use for the CD2BP1 protein and its encoding nucleic acids.
Career Highlights
Throughout his career, Wengian An has worked with various companies, including Wyeth. His innovative research has contributed to advancements in understanding potassium channels and their interactions, which are crucial for numerous physiological processes.
Collaborations
Wengian An has collaborated with notable colleagues such as Huai-Ping Ling and Kenneth Rhodes. These collaborations have likely enriched his research and contributed to the successful development of his patents.
Conclusion
Wengian An's contributions to the field of biochemistry, particularly in potassium channel research, highlight his role as an influential inventor. His patents reflect significant advancements that may lead to important therapeutic applications in the future.